Applying a single molecular probe to monitor biomarkers in multiple, complementary imaging modalities is highly desirable to ascertain detection and to avoid the complexity associated with the use of agents of different chemical entities. We demonstrate the versatility of lanthanide complexes with respect to their potential for enzymatic detection in NIR luminescence, CEST and T1 MR imaging, controlled by the nature of the Ln3+ ion.
A lire aussi
Le CBM recrute !
11 July 2025
par Isabelle Frapart
The CBM is recruiting!
11 July 2025
par Isabelle Frapart
Participation d'une équipe du CBM au Congrès national AMCSTI 2025
08 July 2025
par Isabelle Frapart